Advanced seminoma--treatment results and prognostic factors for survival after first-line, cisplatin-based chemotherapy and for patients with recurrent disease: a single-institution experience in 145 patients.

Gholam, Dany; Fizazi, Karim; Terrier-Lacombe, Marie-Jose; Jan, Pascale; Culine, Stephane; Theodore, Christine

Gholam, Dany; Fizazi, Karim; Terrier-Lacombe, Marie-Jose; Jan, Pascale; Culine, Stephane; Theodore, Christine.

Affiliation

Gholam D; Department of Medicine, Institut Gustave Roussy, Villejuif, France.

Cancer ; 98(4): 745-52, 2003 Aug 15.

Article in En | MEDLINE | ID: mdl-12910518

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Cisplatin/administration & dosage; Seminoma/drug therapy; Seminoma/secondary; Testicular Neoplasms/drug therapy; Adult; Central Nervous System Neoplasms/secondary; Humans; Liver Neoplasms/secondary; Lymphatic Metastasis; Male; Middle Aged; Prognosis; Retrospective Studies; Seminoma/mortality; Survival Rate; Testicular Neoplasms/mortality; Testicular Neoplasms/pathology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Testicular Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Cisplatin / Seminoma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2003 Document type: Article Affiliation country: France Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links